SCHEDULE: Deerfield Reduces Indivior Stake Below 5%

Deerfield Management and its affiliates have reported a reduction in their beneficial ownership of Indivior PLC ordinary shares to 3.70%, falling below the 5% threshold.

Summary

• Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., and James E. Flynn (collectively, "Reporting Persons") filed an Amendment No. 3 to their Schedule 13G for Indivior PLC.
• As of November 10, 2025, the Reporting Persons beneficially owned 4,614,498 Ordinary Shares of Indivior PLC.
• This represents 3.70% of Indivior PLC's outstanding Ordinary Shares.
• The Reporting Persons previously held 6,986,811 Ordinary Shares, or 5.6% of the outstanding shares, as of September 30, 2025.
• The Reporting Persons ceased to beneficially own more than 5% of the outstanding Ordinary Shares as of November 10, 2025.
• All Reporting Persons share voting and dispositive power over the 4,614,498 shares.

Sentiment

Score: 4

Explanation: The reduction in a significant institutional investor's stake below the 5% threshold is generally viewed as a moderately negative signal, potentially indicating reduced confidence or a strategic shift by the investor.

Positives

• NA

Negatives

• A significant institutional investor group, Deerfield Management, has reduced its beneficial ownership in Indivior PLC from 5.6% to 3.70%.
• The reduction means the investor group no longer holds a stake above the 5% threshold, which can be interpreted as a decrease in institutional confidence or a reallocation of capital.

Risks

• Reduced institutional ownership may lead to decreased investor confidence in Indivior PLC.
• The sale of a significant block of shares by a major investor could put downward pressure on the stock price.

Future Outlook

NA

Industry Context

This filing reflects a change in an institutional investor's position in a pharmaceutical company. Such changes are common in the investment landscape and can be driven by various factors, including portfolio rebalancing, changes in investment strategy, or evolving views on the company's prospects or the broader pharmaceutical sector. Without further context from Deerfield, it is difficult to pinpoint the exact driver.

Stakeholder Impact

• Shareholders: May interpret the reduction in institutional ownership as a negative signal, potentially impacting stock price and investor sentiment.

Key Dates

Recommendation

The filing indicates a reduction in a significant institutional investor's stake below the 5% threshold. While this is a notable event, it does not provide sufficient information to warrant a 'buy' or 'sell' recommendation without further analysis of Indivior PLC's fundamentals, market conditions, and the investor's specific reasons for reducing their position. A 'hold' recommendation is appropriate as investors should monitor for further developments and conduct their own due diligence.

Keywords

Indivior PLC, Deerfield Management, Schedule 13G, Beneficial Ownership, Shareholding, Institutional Investor, Equity Stake, G4766E116